Beijing Konruns Pharmaceutical Co.,Ltd. (SHA:603590)
China · Delayed Price · Currency is CNY 30.41
+1.22 (4.18%)
Jun 23, 2026, 3:00 PM CST
SHA:603590 Market Cap
SHA:603590 has a market cap or net worth of 4.79 billion as of June 23, 2026. Its market cap has increased by 1.72% in one year.
Market Cap
4.79B
Enterprise Value
4.62B
Revenue
917.99M
Ranking
n/a
PE Ratio
28.70
Stock Price
30.41
Market Cap Chart
Since August 27, 2018, SHA:603590's market cap has decreased from 5.61B to 4.79B, a decrease of -14.58%. That is a compound annual growth rate of -1.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 4.79B | -24.21% |
| Dec 31, 2025 | 6.32B | 69.72% |
| Dec 31, 2024 | 3.72B | -37.51% |
| Dec 29, 2023 | 5.96B | 52.69% |
| Dec 30, 2022 | 3.90B | -23.24% |
| Dec 31, 2021 | 5.08B | -12.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anhui Huaheng Biotechnology | 5.20B |
| Shanghai Serum Bio-Technology | 5.17B |
| Novogene | 5.06B |
| Shenzhen Weiguang Biological Products | 5.03B |
| Shouyao Holdings (Beijing) Co., LTD. | 4.82B |
| PharmaResources (Shanghai) | 4.76B |
| Wuhan Hvsen Biotechnology | 4.69B |
| R&G PharmaStudies | 4.52B |